Literature DB >> 26221232

MiR-300 regulate the malignancy of breast cancer by targeting p53.

Xiao-Heng Xu1, Da-Wei Li2, Hui Feng1, Hong-Mei Chen1, Yan-Qiu Song1.   

Abstract

OBJECTIVE: In this study, we investigated the role of miR-300 in regulating cell proliferation and invasion of breast cancer (BC) cells.
METHODS: MicroRNA and protein expression patterns were compared between breast cancer tissue and normal tissue and between two different prognostic groups. The up-regulation of miR-300 was confirmed by real-time reverse transcription polymerase chain reaction and its expression was analyzed in MCF-7 breast cancer cells.
RESULTS: We observed that miR-300 expression was frequently and dramatically up-regulated in human breast cancer tissues and cell lines compared with the matched adjacent normal tissues and cells. We further showed that transient and stable over-expression of miR-300 could promote cell proliferation and cell cycle progression. Moreover, p53, a key inhibitor of cell cycle, was verified as a direct target of miR-300, suggesting that miR-300 might promote breast cancer cell proliferation and invasion by regulating p53 expression.
CONCLUSION: Our findings indicated that miR-300 up-regulation might exert some sort of antagonistic function by targeting p53 in breast cancer cell proliferation during breast tumorigenesis.

Entities:  

Keywords:  MCF-7; MiR-300; breast cancer; p53; target therapy

Year:  2015        PMID: 26221232      PMCID: PMC4509177     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  35 in total

1.  microRNA-155 promotes the proliferation of prostate cancer cells by targeting annexin 7.

Authors:  Zhi-Kang Cai; Qi Chen; Yan-Bo Chen; Meng Gu; Da-Chao Zheng; Juan Zhou; Zhong Wang
Journal:  Mol Med Rep       Date:  2014-10-22       Impact factor: 2.952

Review 2.  Prognostic and clinicopathological significance of microRNA-21 overexpression in breast cancer: a meta-analysis.

Authors:  Fei Pan; Hui Mao; Ling Deng; Guangchao Li; Peiliang Geng
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

3.  Effects of differential distribution of microvessel density, possibly regulated by miR-374a, on breast cancer prognosis.

Authors:  Jian-Yi Li; Yang Zhang; Wen-Hai Zhang; Shi Jia; Ye Kang; Rui Tian
Journal:  Asian Pac J Cancer Prev       Date:  2013

4.  MicroRNA-125b expression in gastric adenocarcinoma and its effect on the proliferation of gastric cancer cells.

Authors:  Zhao-Xu Yang; Cheng-Yi Lu; Yan-Ling Yang; Ke-Feng Dou; Kai-Shan Tao
Journal:  Mol Med Rep       Date:  2012-10-26       Impact factor: 2.952

5.  miR‑96 functions as a tumor suppressor gene by targeting NUAK1 in pancreatic cancer.

Authors:  Xuan Huang; Wei Lv; Jian-Hua Zhang; Da-Lin Lu
Journal:  Int J Mol Med       Date:  2014-09-19       Impact factor: 4.101

6.  MicroRNA-302 replacement therapy sensitizes breast cancer cells to ionizing radiation.

Authors:  Zhongxing Liang; Jeffrey Ahn; Donna Guo; John R Votaw; Hyunsuk Shim
Journal:  Pharm Res       Date:  2012-11-27       Impact factor: 4.200

7.  miR-10b*, a master inhibitor of the cell cycle, is down-regulated in human breast tumours.

Authors:  Francesca Biagioni; Noa Bossel Ben-Moshe; Giulia Fontemaggi; Valeria Canu; Federica Mori; Barbara Antoniani; Anna Di Benedetto; Raffaela Santoro; Sabrina Germoni; Fernanda De Angelis; Anna Cambria; Roi Avraham; Giuseppe Grasso; Sabrina Strano; Paola Muti; Marcella Mottolese; Yosef Yarden; Eytan Domany; Giovanni Blandino
Journal:  EMBO Mol Med       Date:  2012-11       Impact factor: 12.137

8.  miRNA target enrichment analysis reveals directly active miRNAs in health and disease.

Authors:  Israel Steinfeld; Roy Navon; Robert Ach; Zohar Yakhini
Journal:  Nucleic Acids Res       Date:  2012-12-02       Impact factor: 16.971

9.  miR-638 mediated regulation of BRCA1 affects DNA repair and sensitivity to UV and cisplatin in triple-negative breast cancer.

Authors:  Xiaohui Tan; Jin Peng; Yebo Fu; Shejuan An; Katayoon Rezaei; Sana Tabbara; Christine B Teal; Yan-gao Man; Rachel F Brem; Sidney W Fu
Journal:  Breast Cancer Res       Date:  2014-09-17       Impact factor: 6.466

10.  Progesterone downregulation of miR-141 contributes to expansion of stem-like breast cancer cells through maintenance of progesterone receptor and Stat5a.

Authors:  J Finlay-Schultz; D M Cittelly; P Hendricks; P Patel; P Kabos; B M Jacobsen; J K Richer; C A Sartorius
Journal:  Oncogene       Date:  2014-09-22       Impact factor: 9.867

View more
  12 in total

1.  miR-300 mitigates cancer-induced bone pain through targeting HMGB1 in rat models.

Authors:  Chenglong Liu; Jianping Yang; Haihua Liu; Tian Xia; Fei Zhang
Journal:  Genes Genomics       Date:  2019-12-23       Impact factor: 1.839

Review 2.  Regulation of epithelial-mesenchymal transition through microRNAs: clinical and biological significance of microRNAs in breast cancer.

Authors:  Fu Peng; Liang Xiong; Hailin Tang; Cheng Peng; Jianping Chen
Journal:  Tumour Biol       Date:  2016-09-19

3.  MiR-300 suppresses laryngeal squamous cell carcinoma proliferation and metastasis by targeting ROS1.

Authors:  Wensheng Ge; Chaodong Han; Jing Wang; Yunping Zhang
Journal:  Am J Transl Res       Date:  2016-09-15       Impact factor: 4.060

Review 4.  Roles for MDC1 in cancer development and treatment.

Authors:  Sophie E Ruff; Susan K Logan; Michael J Garabedian; Tony T Huang
Journal:  DNA Repair (Amst)       Date:  2020-08-11

5.  MicroRNA-410-5p as a potential serum biomarker for the diagnosis of prostate cancer.

Authors:  Jiaqi Wang; Huamao Ye; Dandan Zhang; Yijun Hu; Xiya Yu; Long Wang; Changjing Zuo; Yongwei Yu; Guixia Xu; Shanrong Liu
Journal:  Cancer Cell Int       Date:  2016-02-19       Impact factor: 5.722

6.  Inhibition of miR301 enhances Akt-mediated cell proliferation by accumulation of PTEN in nucleus and its effects on cell-cycle regulatory proteins.

Authors:  Mayur V Jain; Ahmad Shareef; Wirginia Likus; Artur Cieślar-Pobuda; Saeid Ghavami; Marek J Łos
Journal:  Oncotarget       Date:  2016-04-12

Review 7.  microRNA regulators of apoptosis in cancer.

Authors:  Octavian Bucur
Journal:  Discoveries (Craiova)       Date:  2016-04-01

8.  MicroRNA-300 inhibited glioblastoma progression through ROCK1.

Authors:  Fucheng Zhou; Yang Li; Zhen Hao; Xuanxi Liu; Liang Chen; Yu Cao; Zuobin Liang; Fei Yuan; Jie Liu; Jianjiao Wang; Yongri Zheng; Deli Dong; Shan Bian; Baofeng Yang; Chuanlu Jiang; Qingsong Li
Journal:  Oncotarget       Date:  2016-06-14

9.  MicroRNA-300 suppresses metastasis of oral squamous cell carcinoma by inhibiting epithelial-to-mesenchymal transition.

Authors:  Yuanyuan Kang; Ying Zhang; Yan Sun; Yan Wen; Fuli Sun
Journal:  Onco Targets Ther       Date:  2018-09-10       Impact factor: 4.147

10.  LncRNA FLVCR1-AS1 promotes proliferation, migration and activates Wnt/β-catenin pathway through miR-381-3p/CTNNB1 axis in breast cancer.

Authors:  Zhiyu Pan; Junbin Ding; Zhen Yang; Huaqing Li; Hongjian Ding; Qian Chen
Journal:  Cancer Cell Int       Date:  2020-06-05       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.